COMMUNIQUÉS West-GlobeNewswire

Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote
16/09/2019
APAC Vote Confirms Benefit of Oral Immunotherapy for Peanut Allergy; Paves Way for Relief for Thousands of Peanut Allergy Sufferers New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based [...]
Transactions under Novozymes’ stock buyback program
16/09/2019
Please read the full announcement in the attached PDF Attachment 2019_36_Stock_Buybackprogram_EN
Correction: Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act
16/09/2019
Please read the full announcement here Attachment 2019_35_Correction_Summary_of_capital_reduction_EN
CellaVision invites to a telephone and audio webcast on September 17, at 11:00 CET to present the signing of an agreement to acquire the French company RAL Diagnostics
16/09/2019
The information was submitted to the public on September 16, 2019 at 18:45 CET CellaVision AB (publ) announced on September 16, 2019, at 18:30 CET that the company has signed an agreement to acquire the French company [...]
CellaVision AB to acquire RAL Diagnostics
16/09/2019
A unique combination of high-quality sample preparation and world-leading digital cell morphology. The information was released for public disclosure on September 16, 2019, at 18:30 CET CellaVision AB is today [...]
Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs
16/09/2019
PLX-R18 is currently in development as a countermeasure for acute radiation syndrome and as a treatment for incomplete recovery following hematopoietic cell transplantation Data from 1 st and 2 nd cohorts of [...]
PHASTAR Looks to Expand its Global Footprint with U.S. West Coast Office
16/09/2019
DURHAM, N.C. and LONDON, Sept. 16, 2019 (GLOBE NEWSWIRE) -- PHASTAR , a global CRO, is pursuing an aggressive growth strategy that will include the establishment of a U.S. west coast office in California. The company [...]
Sanofi: information concerning the total number of voting rights and shares, August 2019
16/09/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
16/09/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Virbac: operating profit on the rise in the first half of 2019
16/09/2019
Operating profit on the rise in the first half of 2019 CONSOLIDATED DATA AS OF JUNE 30 in € million 2019 2018 % change 2019/2018 Revenue from ordinary activities 463.7 430.0 +7.9% Evolution at constant exchange rates +6 [...]
Virbac : résultat opérationnel courant du premier semestre 2019 en forte croissance
16/09/2019
Résultat opérationnel courant du premier semestre 2019 en forte croissance CHIFFRES CONSOLIDÉS AU 30 JUIN en millions € 2019 2018 Évolution 2019/2018 Chiffre d’affaires 463,7 430,0 +7,9% Évolution à taux de change [...]
Virbac : Rapport financier semestriel 2019
16/09/2019
Ci-joint le rapport financier semestriel 2019 de Virbac Pièce jointe Rapport financier semestriel_Juin 2019
Virbac : Half-yearly financial report 2019
16/09/2019
Please find attached 2019 Half-yearly financial report of Virbac Attachment Half-yearly financial report_June 2019
Acacia Pharma Group plc - Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
16/09/2019
Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Cambridge, UK and Indianapolis, US – 16 September 2019: Acacia Pharma Group plc (the "Company”) (EURONEXT: ACPH), a [...]
HEXO Corp’s Agnes Kwasniewska named Master Grower of the Year
16/09/2019
Canada’s first female Master Grower recognized at the inaugural Grow Up Awards GATINEAU, Quebec, Sept. 16, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) is thrilled to announce [...]
Agnes Kwasniewska de HEXO Corp remporte le prix de Maître Cultivateur de l'année
16/09/2019
Première femme maître cultivatrice du Canada récompensée lors de la cérémonie inaugurale des prix Grow Up GATINEAU, Québec, 16 sept. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE : [...]
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
16/09/2019
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)
16/09/2019
Pathway Helps Physicians Better Identify Which Patients to Treat with Vertebral Augmentation, Which to Manage with Conservative Care DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader [...]
Innovation Pharmaceuticals Announces Successful Formulation of Oral Brilacidin Tablets; Upcoming Clinical Trial to Target Delivery to the Colon
16/09/2019
BEVERLY, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that BDD Pharma, the Company’s [...]

Pages